Study details
Enrolling now
Exploring, Predicting, and Intervening on Long-term Viral Suppression Electronically
University of California, Los Angeles
NCT IDNCT06370780ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,000
Study length
about 4.2 years
Ages
18+
Locations
1 site in CA
What this study is about
This trial is testing a treatment called EPI LOVE to help people with HIV achieve and maintain viral suppression. The goal is to understand the factors that contribute to long-term viral suppression in different groups of people living with HIV, including those who are Black, use drugs, are young adults, or live in rural areas.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.EPI LOVE
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Immune, Infectious